Inactive

1. Amendment No: 0002 is issued to RFP 15DDHQR00000016 to provide the Government's response to questions. (See attached amendment 0002). Diversion Control’s Drug & Chemical Evaluation Section requires... 1. Amendment No: 0002 is issued to RFP 15DDHQR00000016 to provide the Government's response to questions. (See attached amendment 0002). Diversion Control’s Drug & Chemical Evaluation Section requires a new contract to replace the current BPA for DEA’s Toxicology Testing Program (DEA TOX). DEA would require a contractor to analyze the biological samples provided from such overdoses related to abuse of various drugs being encountered.